Form 4: Lemaitre Vascular Inc. Executive David B. Roberts Reports Stock Transactions

David B. Roberts, President and Director of Lemaitre Vascular Inc., reported the acquisition of 12 shares and the disposal of 106 shares of common stock on December 2, 2024.

Summary

• David B. Roberts, a director and President of Lemaitre Vascular Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On December 2, 2024, Roberts acquired 12 shares of common stock through the release of dividend equivalent rights.
• On the same day, he disposed of 106 shares to cover tax obligations related to the vesting of restricted stock units.
• The shares were disposed of at a price of $105.47 per share.
• Following these transactions, Roberts directly owns 14,020 shares of Lemaitre Vascular Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a routine filing of stock transactions by an executive, with no indication of positive or negative sentiment.

Industry Context

This is a routine filing related to executive stock transactions and is common for publicly traded companies. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The transactions reported are typical for executives receiving stock-based compensation and managing tax obligations.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they are related to executive compensation and tax obligations.

Key Dates

Keywords

Lemaitre Vascular Inc., stock transaction, Form 4, insider trading, David B. Roberts, dividend equivalent rights, restricted stock units, tax obligations